Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis
Jiaying Wang, Jiajia Wang, Jincheng Wang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases
Wei He, Neha Kapate, C. Wyatt Shields, et al.
Advanced Drug Delivery Reviews (2019) Vol. 165-166, pp. 15-40
Open Access | Times Cited: 197
The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
Katja Badanjak, Sonja Fixemer, Semra Smajić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4676-4676
Open Access | Times Cited: 190
Bruton tyrosine kinase inhibitors for multiple sclerosis
Julia Krämer, Amit Bar‐Or, Timothy J. Turner, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 5, pp. 289-304
Open Access | Times Cited: 99
Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
Emily Kamma, Wendy O Lasisi, Cole D. Libner, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 95
The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis
Monokesh Kumer Sen, David A. Mahns, Jens R. Coorssen, et al.
Glia (2022) Vol. 70, Iss. 7, pp. 1215-1250
Open Access | Times Cited: 92
Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development
Valentina Pegoretti, Kathryn A. Swanson, John R. Bethea, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 119
TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions
Stefano Raffaele, Marta Lombardi, Claudia Verderio, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2145-2145
Open Access | Times Cited: 104
Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes
Harkiranpreet Kaur Dhaliwal, Yingfang Fan, Jonghan Kim, et al.
Molecular Pharmaceutics (2020) Vol. 17, Iss. 6, pp. 1996-2005
Closed Access | Times Cited: 98
Re-Examining the Role of TNF in MS Pathogenesis and Therapy
Diego Fresegna, Silvia Bullitta, Alessandra Musella, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2290-2290
Open Access | Times Cited: 78
Ketogenic diet attenuates neuroinflammation and induces conversion of M1 microglia to M2 in an EAE model of multiple sclerosis by regulating the NF-κB/NLRP3 pathway and inhibiting HDAC3 and P2X7R activation
Wei Sun, Qingpeng Wang, Ruiyan Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 15, pp. 7247-7269
Closed Access | Times Cited: 24
Microglia in the context of multiple sclerosis
Xue Zhang, Fang Chen, Mingyue Sun, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 23
Immune cells: potential carriers or agents for drug delivery to the central nervous system
Shanshan Zhang, Ruo-Qi Li, Zhong Chen, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Microglial NLRP3 inflammasome activation in multiple sclerosis
Melis Olcum, Bora Tastan, Cagla Kiser, et al.
Advances in protein chemistry and structural biology (2019), pp. 247-308
Closed Access | Times Cited: 68
Microglia-targeting nanotherapeutics for neurodegenerative diseases
Nanxia Zhao, Nicola L. Francis, Hannah Calvelli, et al.
APL Bioengineering (2020) Vol. 4, Iss. 3
Open Access | Times Cited: 66
Lipid nanocapsules to enhance drug bioavailability to the central nervous system
Rui Pedro Moura, Catarina Pacheco, Ana Paula Pêgo, et al.
Journal of Controlled Release (2020) Vol. 322, pp. 390-400
Closed Access | Times Cited: 59
Effect of Inflammation on Female Gonadotropin-Releasing Hormone (GnRH) Neurons: Mechanisms and Consequences
Klaudia Barabás, Edina Szabó‐Meleg, István M. Ábrahám
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 529-529
Open Access | Times Cited: 58
Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis
Stefano Pluchino, Jayden A. Smith, Luca Peruzzotti-Jametti
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 898-912
Closed Access | Times Cited: 52
Retinal and Brain Microglia in Multiple Sclerosis and Neurodegeneration
Soyoung Choi, Li Guo, M. Francesca Cordeiro
Cells (2021) Vol. 10, Iss. 6, pp. 1507-1507
Open Access | Times Cited: 47
CNS border-associated macrophages in the homeostatic and ischaemic brain
Gabriela Gerganova, Alexandra Riddell, Alyson A. Miller
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108220-108220
Open Access | Times Cited: 35
Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis
Antoine Fournier, Olivier Tastet, Marc Charabati, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases
Sanaz Keshavarz Shahbaz, Khadije Koushki, Samaneh Keshavarz Hedayati, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2793-2824
Closed Access | Times Cited: 7
Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment
Angela Dziedzic, Karina Maciak, Elżbieta Miller, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3858-3858
Open Access | Times Cited: 6
A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis
Laura Airas, Robert Bermel, Tanuja Chitnis, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access | Times Cited: 6
Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE)
Vahid Reza Askari, Vafa Baradaran Rahimi, Seyed Abbas Tabatabaee, et al.
International Immunopharmacology (2019) Vol. 77, pp. 105923-105923
Closed Access | Times Cited: 45
Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration
Shashank Kumar Maurya, Neetu Bhattacharya, Suman Mishra, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top